The Food and Drug Administration has approved at-home testing kits that target flu, COVID-19 and RSV, all in one swab. The test, called “The Pixel,” is manufactured by Labcorp.

We may use terms like cold and the flu as if they are the same thing, but there are some key differences between them.

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the CDC, RSV symptoms make it difficult to distinguish it from the common ...

Public health experts have continued to urge people to test, particularly as numbers rise. But beyond the at-home test kits, lab PCR tests have become more challenging to access - and in some ...

The US Food and Drug Administration approved nirsevimab to protect newborns from respiratory syncytial virus, or RSV, on Monday. Nirsevimab, which will be sold under the brand name Beyfortus, is ...

The good news is that even as cases rise and will likely continue to, new as well as tried and true vaccines are available to target COVID-19, influenza and respiratory syncytial virus, or RSV.

So far this year, the CDC estimates that 5.3 million people nationwide have had the flu, and the virus has hospitalized 63,000 people, as well as contributed to 2,700 deaths, including 11 children.

Among 37,000 people over age 60 in 22 countries, the vaccine was 83.7% effective in reducing moderate RSV illness, defined as two or more symptoms of the disease, and 82.4% effective in reducing ...

The Food and Drug Administration has approved at-home testing kits that target flu, COVID-19 and RSV, all in one swab. The test, called "The Pixel," is manufactured by Labcorp.